Anemias Archives - Page 20 of 21 - MPR

Anemias

Nulecit Approved for Iron Deficiency Anemia

Watson and GeneraMedix announced that Nulecit, a generic of Ferrlecit (sodium ferric gluconate complex in sucrose injection; sanofi-aventis), has been approved for the treatment of iron deficiency anemia in patients ≥6 years undergoing chronic hemodialysis who are receiving supplemental epoetin therapy.

First Prospective Randomized Study Demonstrates Safety, Efficacy of Transfusion Therapy in Adults With Sickle Cell Disease

Transfusion therapy in adults with sickle cell disease (SCD) is safe and improves or stabilizes critical laboratory markers, decreases serious sickle cell anemia-related adverse events, and decreases hospitalizations, preliminary data from the first prospective randomized study of the safety and efficacy of transfusion therapy in adults with SCD has found. The study was presented at the 52nd American Society of Hematology Annual Meeting and Exposition.

Iron Supplementation of Erythropoiesis-Stimulating Agents Increases Hematopoietic Response Rates in Patients With Cancer and Chemotherapy-Induced Anemia

When compared with using erythropoiesis-stimulating agents (ESA) alone or placebo, iron supplementation of ESAs significantly increases hematopoietic response rates and reduces the number of red blood cell (RBC) transfusions in patients with chemotherapy-induced anemia (CIA), results of the first systematic review and meta-analysis have found. The study was presented at the 52nd American Society of Hematology Annual Meeting and Exposition.